A42.81 Actinomycotic meningitis

Name of the Condition

• Actinomycotic meningitis

Summary

Actinomycotic meningitis is a rare bacterial infection of the meninges caused by Actinomyces species, leading to granulomatous inflammation and abscess formation. The condition progresses slowly and may involve adjacent brain or spinal tissues if untreated, with potential for neurological complications.

Causes

Actinomycotic meningitis is caused by anaerobic or microaerophilic bacteria from the genus Actinomyces, most commonly Actinomyces israelii. These bacteria are part of the normal flora in the mouth, gastrointestinal tract, or other mucosal surfaces but can invade the meninges through direct extension from adjacent infections, trauma, or surgical procedures.

Risk Factors

• Direct extension from actinomycosis in adjacent sites (e.g., skull, sinuses, or spine)
• Head trauma or neurosurgical procedures
• Immunocompromised states (e.g., diabetes, HIV)
• Chronic infections or fistulas involving the cranial or spinal regions
• Poor wound care or delayed healing after head/neck surgery
• Foreign bodies or implants near the meninges

Symptoms

• Persistent headache, often severe or worsening
• Fever, neck stiffness, or photophobia
• Altered mental status, confusion, or lethargy
• Nausea, vomiting, or seizures
• Focal neurological deficits (e.g., weakness, sensory changes)
• Signs of increased intracranial pressure

Diagnosis

Diagnosis is based on clinical presentation, imaging (e.g., MRI or CT showing meningeal enhancement, abscesses, or inflammation), and microbiological confirmation (e.g., cerebrospinal fluid culture or tissue biopsy identifying Actinomyces species). Lumbar puncture may reveal elevated white blood cells, protein, or characteristic sulfur granules.

Treatment Options

Treatment typically involves prolonged courses of high-dose intravenous antibiotics (e.g., penicillin or amoxicillin) followed by oral therapy for several months. Surgical intervention may be necessary to drain abscesses or debride infected tissue. Adjunctive therapies, such as corticosteroids, may be used to reduce inflammation.

Prognosis and Follow-Up

Prognosis depends on early diagnosis and treatment; delayed intervention can lead to permanent neurological damage. Follow-up includes monitoring for symptom resolution, repeat imaging if needed, and ensuring completion of antibiotic therapy. Long-term neurological sequelae may require rehabilitation.

Complications

• Permanent neurological deficits (e.g., cognitive impairment, motor weakness)
• Hydrocephalus or increased intracranial pressure
• Meningeal scarring or adhesions
• Recurrent infection if treatment is incomplete
• Seizure disorders
• Death (in severe or untreated cases)

Lifestyle & Prevention

• Maintain good oral and overall hygiene to reduce bacterial overgrowth.
• Promptly treat infections in adjacent sites (e.g., sinusitis, dental abscesses).
• Follow post-surgical care instructions to prevent wound infections.
• Manage chronic conditions (e.g., diabetes) to support immune function.
• Avoid trauma to the head or spine when possible.

When to Seek Professional Help

Seek immediate medical attention for severe headache, fever, neck stiffness, confusion, or neurological symptoms (e.g., weakness, seizures). Early evaluation is critical to prevent complications.

Tips for Medical Coders

Document the clinical findings, imaging results, and microbiological confirmation to support the diagnosis. Note the involvement of the meninges and any associated complications. Ensure the code A42.81 is used only when the primary site of infection is the meninges, with no other specified actinomycosis sites documented.